Year: 2020
Type: review
Abstract: Despite accelerating progress towards schistosomiasis control in sub-Saharan Africa, several age groups have been eclipsed by current treatment and monitoring strategies that mainly focus on school-aged children. As schistosomiasis poses a threat to people of all ages, unfortunate gaps exist in current treatment coverage and associated monitoring efforts, preventing subsequent health benefits to preschool-aged children as well as certain adolescents and adults. Expanding access to younger ages through the forthcoming pediatric praziquantel formulation and improving treatment coverage in older ages is essential. This should occur alongside formal inclusion of these groups in large-scale monitoring and evaluation activities. Current omission of these age groups from treatment and monitoring exacerbates health inequities and has long-term consequences for sustainable schistosomiasis control.
Source: Trends in Parasitology
Language: English
Subfield: Parasitology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,000
Funders: Doris Duke Charitable Foundation, Thrasher Research Fund, Wellcome Trust, National Institute for Health and Care Research, National Institutes of Health, Medical Research Council, Engineering and Physical Sciences Research Council, European Research Council, National Institute of Allergy and Infectious Diseases
Awards: Novel low cost diagnostic tools and their impact in Africa, G2146058287, G2256170820, G2263435419, Paediatric Schistosomiasis: indirect, long-term impacts on health., Cultural, social and economic influences on ongoing Schistosoma mansoni transmission, despite a decade of mass treatment, and the potential for change, G3906896767, G4139447320, G8328390906, G9000302729
OpenAlex ID: W3024413639